POINT Biopharma Global In... (PNT)
NASDAQ: PNT
· Real-Time Price · USD
12.50
0.02 (0.16%)
At close: Dec 26, 2023, 10:00 PM
POINT Biopharma Global Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -24.77M | -25.41M | -16.53M | 163.27M | -24.01M | -24.58M | -16.38M | -14.2M | -17.12M | -8.8M | -5.78M |
Depreciation & Amortization | 863.92K | 784.7K | 537.63K | 414.03K | 396.92K | 359.84K | 224.23K | 11.84K | n/a | n/a | n/a |
Stock-Based Compensation | 1.88M | 1.71M | 1.01M | 998.53K | 1.08M | 1.03M | 440.45K | 370.79K | 348.12K | 1.11M | 477.25K |
Other Working Capital | 506.3K | -44.06M | -11.99M | 68.74M | 3.61M | 2.37M | 1.31M | 2.16M | 3.73M | -2.29M | -2.75M |
Other Non-Cash Items | 195.59K | -3.91M | -3.16M | -1.52M | -372.68K | -128.15K | n/a | -11.84K | 6.18K | 167.07K | 2.8K |
Deferred Income Tax | -1.45M | n/a | n/a | 1.45M | n/a | n/a | n/a | 2.87K | -101.49K | n/a | n/a |
Change in Working Capital | -4.84M | -47.51M | -4.25M | 72.3M | 581.48K | 2.74M | 5.23M | 510.99K | 2.31M | 1.67M | -5.66M |
Operating Cash Flow | -28.13M | -74.34M | -22.39M | 236.92M | -22.33M | -20.58M | -10.49M | -13.31M | -14.56M | -5.86M | -10.97M |
Capital Expenditures | -6.39M | -7.33M | -3.52M | -2.07M | -7.62M | -2.14M | -940.93K | -697.6K | -2.25M | -5.67M | -186.8K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -1.01M | 32.77M | -149.52M | -87.66M | -39.28M | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | -5M | n/a | n/a | n/a | -126.56M | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -7.4M | 20.44M | -153.04M | -89.73M | -46.89M | -128.7M | -940.93K | -697.6K | -2.25M | -5.67M | -186.8K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -152.31K | 52.42K | 145.86K | 13.46M | 116.9M | 3.46K | 942.00 | -20.54M | -4.11M | 265.43M | 20.45M |
Financial Cash Flow | -152.31K | 52.42K | 145.86K | 13.46M | 116.9M | 3.46K | 942.00 | n/a | -4.11M | 265.43M | 20.45M |
Net Cash Flow | -35.69M | -53.85M | -175.29M | 160.65M | 47.67M | -149.28M | -11.43M | -14.01M | -20.91M | 253.89M | 9.3M |
Free Cash Flow | -34.53M | -81.67M | -25.92M | 234.85M | -29.94M | -22.72M | -11.43M | -14.01M | -16.8M | -11.53M | -11.15M |